Page last updated: 2024-10-28

fasudil and Overweight

fasudil has been researched along with Overweight in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butruille, L1
Mayeur, S1
Duparc, T1
Knauf, C1
Moitrot, E1
Fajardy, I1
Valet, P1
Storme, L1
Deruelle, P1
Lesage, J1

Other Studies

1 other study available for fasudil and Overweight

ArticleYear
Prenatal fasudil exposure alleviates fetal growth but programs hyperphagia and overweight in the adult male rat.
    European journal of pharmacology, 2012, Aug-15, Volume: 689, Issue:1-3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Age Factors; Animals; Female; Fetal Development; Feta

2012
chemdatabank.com